Role of PET/CT in Peritoneal Deposits Assessment

Status Not yet recruiting

Clinical Trial Summary

• Suspected patients known to have a primary malignant tumour, patients with metastasis of unknown primary and had incidental peritoneal lesions and will do PET/CT for assessment of peritoneal deposits

Clinical Trial Description

Suspected patients known to have a primary malignant tumour, patients with metastasis of unknown primary and had incidental peritoneal lesions and will do PET/CT for assessment of peritoneal deposits. we will find its diagnostic role. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT06137417
Study type	Observational
Source	Assiut University
Contact
Status	Not yet recruiting
Phase
Start date	January 1, 2024
Completion date	March 15, 2026

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT03422432` - Prophylactic HIPEC for Colorectal Cancers at High Risk of Developing Peritoneal Metastases	N/A
Not yet recruiting	`NCT06295094` - The Efficacy of PIPAC and Minimally Invasive Radical Resection in High-risk Gastric Cancer Patients.	Phase 2
Recruiting	`NCT05056389` - Normothermic Intraperitoneal Chemotherapy - Long Term in Peritoneal Metastases From Colorectal Cancer (NIPEC-OXA)	Phase 1
Withdrawn	`NCT03682744` - CAR-T Intraperitoneal Infusions for CEA-Expressing Adenocarcinoma Peritoneal Metastases or Malignant Ascites (IPC)	Phase 1
Recruiting	`NCT06367270` - The Application of Pressured Intraperitoneal Aerosol Chemotherapy (PIPAC) for Peritoneal Surface Malignancies	Phase 2
Recruiting	`NCT05623787` - Diagnostic Value of Diffusion-weighted Magnetic Resonance in High-risk Colorectal and Appendiceal Neoplasms	N/A
Not yet recruiting	`NCT05095467` - HIPEC-AS in Patients With Peritoneal Metastasis of the Stomach or Esophagogastric Junction	Phase 2
Completed	`NCT04083547` - Circulating Tumour Cells in Patients With Peritoneal Metastases
Recruiting	`NCT06216561` - Intraperitoneal LSTA1 in CRS-HIPEC	Phase 1
Recruiting	`NCT05277766` - Intraperitoneal Aerosolized Nanoliposomal Irinotecan (Nal-IRI) in Peritoneal Carcinomatosis From Gastrointestinal Cancer	Phase 1
Not yet recruiting	`NCT05318794` - Neoadjuvant Systemic and Peritoneal Chemotherapy for Advanced Gastric Cancer	Phase 2
Completed	`NCT05665257` - Feasibility of Preoperative Inspiratory Muscle Training for Patients With Peritoneal Metastases	N/A
Terminated	`NCT05581719` - A Phase 1/2a Study Evaluating Allocetra-OTS as Monotherapy or in Combination With Anti-PD-1 Therapy for the Treatment of Advanced Solid Tumor Malignancy	Phase 1/Phase 2
Recruiting	`NCT05379790` - Concomitant Intraperitoneal and Systemic Chemotherapy in Patients With Extensive Peritoneal Carcinomatosis of Gastric Origin	Phase 1
Recruiting	`NCT05204173` - Efficacy and Safety of Sintilimab Combined Intraperitoneal and Intravenous Paclitaxel Plus Oral S-1 in Gastric Cancer Patients With Peritoneal Metastasis	Phase 2
Recruiting	`NCT04956068` - PIPAC for Peritoneal Metastases	Phase 1
Recruiting	`NCT04861558` - Efficacy of Hyperthermic Intraperitoneal Chemotherapy	Phase 3
Recruiting	`NCT05340569` - Diagnostic Value of DWI-MRI for Detection of Peritoneal Metastases in High-risk Pancreatic Ductal Adenocarcinoma.	N/A
Recruiting	`NCT03834272` - Feasibility of the LUM Imaging System for Peritoneal Surface Malignancies	Phase 1/Phase 2
Completed	`NCT03733184` - Development of an IDEAL Framework to Standardise Cytoreductive Surgery for Colorectal Peritoneal Metastases